Preferred Buyer Location All Countries Except India
Letrozole tablets USP 2.5 mg is used in the treatment of advanced breast cancer in women. Letrozole is the second in a new class of third-generation selective oral aromatase inhibitors. It acts by blocking the enzyme aromatase, subsequently blocking the production of estrogen. The recommended dose of Letrozole is 2.5 mg once daily, at the same time each day, taken with or without food.